SUMMARY

ACKNOWLEDGEMENTS 
INTRODUCTION 
PREFACE 
FOREWORD 
FIRST PART
HOW BALLOON ANGIOPLASTY WAS INVENTED
INTRODUCTION 
CHAPTER I THE ORIGINS 

THE PRECURSORS TO ANDREAS GRüNTZIG

ANDREAS GRüNTZIG AND THE CONCEPT OF A BALLOON CATHETER

CHAPTER II ANDREAS GRüNTZIG AND THE BIRTH OF BALLOON DILATATION 

CORONARY ANGIOPLASTY IN ANIMALS

CORONARY ANGIOPLASTY IN HUMANS

CHAPTER III THE DEVELOPMENT OF CORONARY ANGIOPLASTY 

ANDREAS GRüNTZIG: INITIAL EXPERIENCE IN ZURICH (1977-80)

ANDREAS GRüNTZIG: EXPERIENCE IN ATLANTA (1980-85)

INDICATION EXPANSION AND GEOFFREY HARTZLER’S ROLE

EQUIPMENT IMPROVEMENT

COMPLICATION MANAGEMENT

THE FRENCH EXPERIENCE

SECOND PART
HOW CORONARY STENTING WAS ESTABLISHED
INTRODUCTION 
CHAPTER I THE CONCEPT OF CORONARY STENTING 

THE PRECURSORS

BALLOON ANGIOPLASTY LIMITATIONS

CHAPTER II THE BARE METAL STENT 

THE ORIGINS

THE SORCERER’S APPRENTICE

THE RANDOMIZED STUDIES

CHAPTER III THE DRUG-ELUTING STENT 

RESTENOSIS IS NOT DEFEATED

THE FIRST-GENERATION WITH A DURABLE POLYMER: CYPHER AND TAXUS

NEW-GENERATIONS OF DRUG-ELUTING STENTS

SAFETY AND EFFICACY OF CORONARY ARTERY STENTS

A DECADE OF DRUG-ELUTING STENTS

CHAPTER IV THE BIORESORBABLE SCAFFOLD 

UNCOVERING THE PROBLEM

THE IGAKI-TAMAI STENT

THE ABSORB BVS

OTHER BIORESORBABLE SCAFFOLDS

EPILOGUE 
BIBLIOGRAPHY 
 
With an unrestricted educational grant from: With an unrestricted educational grant from Boston Scientific